On December 14, 2015, Northwest Biotherapeutics, Inc announced that it responded to shareholder questions about appointments relating to the Company's Board, and an independent investigation of recent allegations in an anonymous internet report and a derivative lawsuit which cites the anonymous internet report. The Company stated that after meetings and deliberations, the Board came to the conclusion that it was not a fit for Elliott Leary to join Company's Board for a number of reasons.